Cipla Chairman Speech

_{Dear Shareholders,}

As we conclude another eventful year, Cipla stands at a significant moment in its history, to reflect on the past 90 years. It was in August, 1935 that our founder, Dr K A Hamied embarked on a journey guided by science, self-reliance and an unshakeable belief that healthcare must ultimately serve humanity. As we commemorate nine decades of Caring for Life,

I see this milestone not merely as a measure of time, but as a reaffirmation of our purpose, one that has guided Cipla at every step of the way.

The lessons we have learnt, over the past 90 years, have shaped the enterprising and enduring spirit of Cipla. The release of a commemorative stamp by the Department of Posts, Government of India, is a national recognition of Cipla''s contribution to public health. The special Amar Chitra Katha edition that narrates Cipla''s story also holds a special significance for me. It captures our legacy in a form that speaks to younger generations and reminds us that science, when guided by compassion, has the power to transform lives.

Over the past seven decades, I have been involved with Cipla and have seen the response to the changing needs of patients and the healthcare systems prevailing worldwide. Cipla began with a commitment to indigenous manufacture of medications, self-reliance and self-sufficiency. Cipla has now grown into a broader global resolve to address medical needs in totality. We are focused on areas where we can make meaningful changes. We have built leadership in respiratory care, advanced complex generic drugs and specialty medicines. We have also strengthened Cipla''s presence across major global markets, such as the US, China, Africa, etc. This continuous journey has been guided by the practical understanding of

where science and access to medicines can have the maximum impact.

Alongside this evolution, Cipla''s ability to deliver quality medicines on a large scale has been supported by sustained investments in research and development, manufacturing skills and scientific innovation. Whether it has been in expanding access to essential therapies, supporting healthcare systems during times of crisis, or advancing sustainability and change initiatives,

Cipla has always acted as a responsible and forward-looking organisation.

This approach is based on scientific excellence and is guided by empathy and humility. It continues to define our role in serving patients, communities and healthcare in general, not only in India, but globally.

The real strength of Cipla has always been its people. From a small group driven by conviction in our early years, we have grown into a global organisation with over 31,000 members who all share Cipla''s strong purpose of Caring for Life. Our progress has been the outcome of collective team effort rather than any individual contribution. We thank all employees, both past and present, whose commitment, integrity and adherence to Cipla''s values have shaped the Company''s journey.

The success of a company cannot be judged by financial performance alone. What truly matters is the quality of the journey and the contribution made to society. Over the last 90 years, Cipla has sought to improve access to medicines and respond to critical healthcare needs. Our pioneering efforts during the HIV/AIDS crisis in the early 2000s, particularly across Africa, remain a defining example of this philosophy in action.

For Cipla, caring for patients has always meant going beyond the boundaries of treatment alone. Through our work in palliative care, we have sought to uphold dignity, comfort, compassion and humanity, for those at the most vulnerable stages of life. This reflects the deeper meaning of Caring for Life, the responsibility to stand by patients and their families with humanity, even when cure may not be possible.

This milestone 90^th year is therefore a moment of shared pride for all who are part of the Cipla family - our employees, partners, the medical community and pharmacists. We express our gratitude to all of them, to the Board, the management team and our shareholders, for their continued support, stewardship and trust.

As we reflect on the past and look towards the future, this year also marks important leadership transitions that ensure continuity of our purpose and vision. We are pleased to welcome Mr P R Ramesh as the Vice-Chairman of Cipla. His experience and association with the Board will serve the Company well as we enter the next phase of our journey. We also welcome Mr Achin Gupta as the new Managing Director and Global Chief Executive Officer of Cipla. We are confident that he will lead Cipla with clarity, responsibility, integrity and vision, while remaining firmly anchored to the values on which this Company was built.

As Cipla completes 90 years, we do so with a sense of pride. This milestone is a reminder of the responsibility we carry forward. As we look ahead to our centenary in 2035, my belief remains unchanged, that Cipla will continue to serve society with integrity, innovation and care, staying true to its purpose of Caring for Life and striving always to improve the quality of life for people everywhere.

Warm regards,

Y K Hamied

Chairman